News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Kafi N. Sanders, MPH

Articles by Kafi N. Sanders, MPH

Therapeutic Dose Assessment of Patient Switching from Atorvastatin to Simvastatin

ByGregory Hess, MD, MBA,Kafi N. Sanders, MPH,Jerrold Hill, PhD,Larry Z. Liu, MD, PhD

June 1st 2007

Latest Updated Articles

Therapeutic Dose Assessment of Patient Switching from Atorvastatin to Simvastatin
Published: June 1st 2007 | Updated:

Trending on AJMC

TrumpRx Launch Brings Savings—and Uncertainty

5 Things to Know About the Oral GLP-1 Era

Exploring Identity, Appearance Experiences Among Patients With Alopecia

Even After 6 Years, Disease Progression Impacts Survival in Mantle Cell Lymphoma

Real-World Evidence Backs Acalabrutinib in CLL Care

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.

Alt Text

Alt Text